Thursday, January 8, 2015

Imprimis Pharmaceuticals Looks to Expand its Ophthalmology

  1. Imprimis Pharmaceuticals Looks to Expand its Ophthalmology ...

    PR Newswire (press release)-10 hours ago
    Importantly, Imprimis' topical compounded drops may be eligible for reimbursement to patients covered by both public and private insurance plans.

No comments: